Joseph G. Wettstein

7.1k total citations · 1 hit paper
91 papers, 5.3k citations indexed

About

Joseph G. Wettstein is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Joseph G. Wettstein has authored 91 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Cellular and Molecular Neuroscience, 49 papers in Molecular Biology and 23 papers in Cognitive Neuroscience. Recurrent topics in Joseph G. Wettstein's work include Neuroscience and Neuropharmacology Research (38 papers), Receptor Mechanisms and Signaling (35 papers) and Neurotransmitter Receptor Influence on Behavior (23 papers). Joseph G. Wettstein is often cited by papers focused on Neuroscience and Neuropharmacology Research (38 papers), Receptor Mechanisms and Signaling (35 papers) and Neurotransmitter Receptor Influence on Behavior (23 papers). Joseph G. Wettstein collaborates with scholars based in United States, Switzerland and France. Joseph G. Wettstein's co-authors include Silvia Gatti, F. Foster, Katharina Wulff, Laurence Ozmen, Lothar Lindemann, Jean‐Luc Moreau, J.L. Junien, Marius C. Hoener, Edilio Borroni and Georg Jaeschke and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Neuron.

In The Last Decade

Joseph G. Wettstein

89 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease

2010 794 citations Katharina Wulff, Silvia Gatti et al. Nature reviews. Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph G. Wettstein United States	36	2.7k	2.3k	1.5k	868	638	91	5.3k
Shari G. Birnbaum United States	39	3.0k 1.1×	2.4k 1.0×	2.0k 1.4×	1.5k 1.8×	518 0.8×	68	7.4k
Amanda J. Roberts United States	52	5.0k 1.8×	2.9k 1.3×	1.7k 1.1×	992 1.1×	399 0.6×	186	9.3k
Thomas Steckler Belgium	41	2.7k 1.0×	1.8k 0.8×	1.7k 1.2×	435 0.5×	289 0.5×	138	6.7k
Claire Rampon France	33	3.5k 1.3×	1.7k 0.7×	2.1k 1.4×	476 0.5×	181 0.3×	62	6.5k
Stephen G. Brickley United Kingdom	32	4.7k 1.8×	2.7k 1.2×	2.2k 1.5×	538 0.6×	164 0.3×	45	6.3k
Yanhua H. Huang United States	37	3.7k 1.4×	2.2k 0.9×	1.5k 1.0×	432 0.5×	265 0.4×	112	5.9k
Venetia Zachariou United States	39	2.9k 1.1×	2.8k 1.2×	814 0.6×	471 0.5×	235 0.4×	92	5.7k
Emilio Merlo Pich Italy	48	3.8k 1.4×	3.7k 1.6×	1.9k 1.3×	782 0.9×	940 1.5×	145	8.9k
Mark D. Underwood United States	42	3.0k 1.1×	1.6k 0.7×	1.1k 0.8×	522 0.6×	253 0.4×	98	6.6k
Barbara A. Sorg United States	41	3.5k 1.3×	1.9k 0.8×	1.3k 0.9×	507 0.6×	213 0.3×	110	5.4k

Countries citing papers authored by Joseph G. Wettstein

Since Specialization

Citations

This map shows the geographic impact of Joseph G. Wettstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph G. Wettstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph G. Wettstein more than expected).

Fields of papers citing papers by Joseph G. Wettstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph G. Wettstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph G. Wettstein. The network helps show where Joseph G. Wettstein may publish in the future.

Co-authorship network of co-authors of Joseph G. Wettstein

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph G. Wettstein. A scholar is included among the top collaborators of Joseph G. Wettstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph G. Wettstein. Joseph G. Wettstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Michalon, Aubin, Andreas Bruns, Céline Risterucci, et al.. (2013). Chronic Metabotropic Glutamate Receptor 5 Inhibition Corrects Local Alterations of Brain Activity and Improves Cognitive Performance in Fragile X Mice. Biological Psychiatry. 75(3). 189–197. 48 indexed citations

Martínez‐Cué, Carmen, Paula Martínez, Noemı́ Rueda, et al.. (2013). Reducing GABA _A α5 Receptor-Mediated Inhibition Rescues Functional and Neuromorphological Deficits in a Mouse Model of Down Syndrome. Journal of Neuroscience. 33(9). 3953–3966. 122 indexed citations

Jagannath, Aarti, Rachel Butler, Sofia I.H. Godinho, et al.. (2013). The CRTC1-SIK1 Pathway Regulates Entrainment of the Circadian Clock. Cell. 154(5). 1100–1111. 161 indexed citations

Revel, Florent G., Claas A. Meyer, Amyaouch Bradaïa, et al.. (2012). Brain-Specific Overexpression of Trace Amine-Associated Receptor 1 Alters Monoaminergic Neurotransmission and Decreases Sensitivity to Amphetamine. Neuropsychopharmacology. 37(12). 2580–2592. 84 indexed citations

Wallace, Tanya L., Theresa M. Ballard, Bruno Pouzet, Wim J. Riedel, & Joseph G. Wettstein. (2011). Drug targets for cognitive enhancement in neuropsychiatric disorders. Pharmacology Biochemistry and Behavior. 99(2). 130–145. 103 indexed citations

Wulff, Katharina, Silvia Gatti, Joseph G. Wettstein, & F. Foster. (2010). Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nature reviews. Neuroscience. 11(8). 589–599. 794 indexed citations breakdown →

Malherbe, Pari, Olivier Roche, Anne Marcuz, et al.. (2010). Mapping the Binding Pocket of Dual Antagonist Almorexant to Human Orexin 1 and Orexin 2 Receptors: Comparison with the Selective OX1 Antagonist SB-674042 and the Selective OX2 Antagonist N-Ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA). Molecular Pharmacology. 78(1). 81–93. 38 indexed citations

Revel, Florent G., et al.. (2009). Rodent models of insomnia: A review of experimental procedures that induce sleep disturbances. Neuroscience & Biobehavioral Reviews. 33(6). 874–899. 71 indexed citations

Lundström, Linda, Bernd Kuhn, Jennifer Beck, et al.. (2009). Mutagenesis and Molecular Modeling of the Orthosteric Binding Site of the mGlu2 Receptor Determining Interactions of the Group II Receptor Antagonist ³H‐HYDIA. ChemMedChem. 4(7). 1086–1094. 12 indexed citations

10.

Lindemann, Lothar, Claas A. Meyer, Karine Jeanneau, et al.. (2007). Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity. Journal of Pharmacology and Experimental Therapeutics. 324(3). 948–956. 258 indexed citations

11.

Petty, Margaret A., et al.. (2003). In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke. European Journal of Pharmacology. 474(1). 53–62. 17 indexed citations

12.

Petty, Margaret A. & Joseph G. Wettstein. (2001). Elements of cerebral microvascular ischaemia. Brain Research Reviews. 36(1). 23–34. 104 indexed citations

13.

Black, Mark D., David E. Selk, Janice M. Hitchcock, Joseph G. Wettstein, & Stephen M. Sorensen. (1999). On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia. Neuropharmacology. 38(9). 1299–1306. 67 indexed citations

14.

Petty, Margaret A. & Joseph G. Wettstein. (1999). White matter ischaemia. Brain Research Reviews. 31(1). 58–64. 43 indexed citations

15.

Broqua, Pierre, et al.. (1996). Antinociceptive effects of neuropeptide Y and related peptides in mice. Brain Research. 724(1). 25–32. 36 indexed citations

16.

Wettstein, Joseph G., Lionel Buéno, & J.L. Junien. (1994). CCK antagonists: Pharmacology and therapeutic interest. Pharmacology & Therapeutics. 62(3). 267–282. 44 indexed citations

17.

Broqua, Pierre, et al.. (1994). Evaluation of the behavioral effects of peptides related to neuropeptide Y. Neuropeptides. 26. 16–16. 5 indexed citations

18.

Zhang, Jing, Louis A. Chiodo, Joseph G. Wettstein, Jean‐Louis Junien, & Arthur S. Freeman. (1992). Acute effects of Sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons. Synapse. 11(4). 267–278. 20 indexed citations

19.

Wettstein, Joseph G., et al.. (1991). Effects of sigma receptor ligands on schedule-controlled behavior of rats: relation to sigma and PCP receptor binding affinity. Psychopharmacology. 104(2). 157–163. 10 indexed citations

20.

Wettstein, Joseph G. & Roger D. Spealman. (1986). Behavioral effects of zopiclone, CL 218,872 and diazepam in squirrel monkeys: antagonism by Ro 15-1788 and CGS 8216.. Journal of Pharmacology and Experimental Therapeutics. 238(2). 522–528. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact